Skip to content

A Neuroimaging Study on the Soothing the Liver and Regulating the Spirit Acupuncture Method for Chronic Migraine Treatment

A Neuroimaging Study on the Soothing the Liver and Regulating the Spirit Acupuncture Method for Chronic Migraine Treatment

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2026001681
Enrollment
Unknown
Registered
2026-07-06
Start date
2026-07-10
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Migraine

Interventions

Acupuncture group:soothing liver and regulating the spirit acupuncture
Healthy Control Group:None

Sponsors

Affiliated Hospital of Shandong University of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. Inclusion criteria for chronic migraine patients: (1) Meet the diagnostic criteria for chronic migraine; (2) Age 18-65 years, right-handed; (3) Have not undergone acupuncture treatment in the past 3 months; (4) Voluntarily participate and sign the informed consent form; (5) Have had migraines for at least 1 year prior to screening, with onset of migraines before the age of 50. 2. Inclusion criteria for healthy subjects: (1) Healthy physical examination, without organic or significant functional diseases; (2) Age 18-65 years, right-handed; (3) Have not undergone acupuncture treatment in the past 3 months; (4) Voluntarily participate and sign the informed consent form.

Exclusion criteria

Exclusion criteria: 1. Those prone to concurrent infections and bleeding, lactating women, pregnant women, and individuals with allergic constitutions (especially those allergic to metal acupuncture needles); 2. Individuals with severe systemic diseases such as cardiovascular, hepatic, renal, or cerebral conditions; 3. Patients with mental disorders or somatization disorders who are unable to independently complete this clinical study; 4. Those who have taken psychotropic or vasoactive medications within the past three months; 5. Individuals with headaches caused by excessive use of analgesic medications; 6. Those with contraindications for MRI scans, such as implanted metallic devices or claustrophobia; 7. Individuals unable to cooperate with the treatment or currently participating in other related clinical trials.

Design outcomes

Primary

MeasureTime frame
Cranial MRI data;Monthly headache days;

Secondary

MeasureTime frame
Visual Analogue Scale;Headache symptom score;migraine-specific quality of life questionnaire;

Countries

China

Contacts

Public ContactJing Han

Affiliated hospital of Shandong University of Traditional Chinese Medicine

hanjing0127@163.com13708927840

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Aug 10, 2026